Senescence Biomarkers Predict Physical Function and Clinical Outcomes After Heart Failure Hospitalization: Insights From REHAB-HF
Seneszenz-Biomarker sagen körperliche Funktion und klinische Outcomes nach Herzinsuffizienz-Hospitalisierung voraus: Erkenntnisse aus REHAB-HF
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 30.10.2026
DOI: 10.1093/gerona/glag256 ↗Auf einen Blick
Bei älteren Patient:innen mit Hospitalisierung wegen ADHF war ein höherer SASP mit schlechterer körperlicher Funktion und geringerem Funktionsgewinn verbunden.
Fragestellung
Besteht bei älteren Erwachsenen mit ADHF-Hospitalisierung ein Zusammenhang zwischen SASP und körperlicher Funktion?
Methode
REHAB-HF mit älteren Erwachsenen nach ADHF-Hospitalisierung; SASP-Messung zu Beginn und nach 3 Monaten; Auswertung mit PCA und multivariablen Regressionsmodellen, adjustiert für Alter, Geschlecht und Interventionsarm.
Ergebnisse
226 Teilnehmende. PC1 war mit schlechterer Funktion assoziiert: SPPB -0,46 (95 %-KI -0,77 bis -0,14) und 6MWD -19,7 Meter (95 %-KI -32,7 bis -6,7). Anstieg des SASP: ΔSPPB -1,80 (95 %-KI -2,58 bis -1,03) und Δ6MWD -49,7 Meter (95 %-KI -77,2 bis -22,1).
Schlussfolgerung der Autor:innen
Höhere SASP-Werte waren bei älteren Patient:innen mit ADHF-Hospitalisierung mit einer schlechteren Erholung der körperlichen Funktion verbunden.
Kernaussagen
- PC1 war mit niedrigerem SPPB und kürzerer 6MWD assoziiert
- Anstieg des SASP ging mit geringerem Funktionsgewinn einher
- 226 Teilnehmende hatten auswertbare Proben
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 30.10.2026. Verfasst von Charles T Semelka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest University School of Medicine, Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Winston Salem, NC, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Acute decompensated heart failure (ADHF) is the most common cause of hospitalization in older adults. Cellular senescence, a hallmark of aging biology, has been implicated in heart failure pathophysiology and functional decline via the pro-inflammatory senescence-associated secretory phenotype (SASP). We evaluated the association between SASP and physical function in older adults hospitalized for ADHF.
Methods
REHAB-HF was a trial of older adults hospitalized for ADHF randomized to a novel physical rehabilitation intervention or attention control. We measured a panel of 18-SASP analytes at in-hospital baseline and at 3-month follow-up. Outcomes included short physical performance battery (SPPB) and 6-minute walk distance (6MWD). Statistical analysis included principal component analysis (PCA) of log- and z-transformed SASP values. Associations were evaluated with multivariable regression models adjusted for age, sex, and intervention arm.
Results
Samples were available for 226 (65%) of the REHAB-HF participants with mean age (SD) 72.3 (8), 53% female, 52% HFpEF, and 53% assigned to rehab intervention. Principal Component 1 (PC1) reflected a coordinated signal across biomarkers of inflammation and immune signaling. PC1 was associated with poorer function at baseline [(SPPB -0.46 [-0.77, -0.14]; p = 0.004 and 6MWD -19.7 meters [-32.7, -6.7]; p = 0.003)]. Increasing SASP over time was associated with clinically significant reduced physical function improvement (ΔSPPB -1.80 [-2.58, -1.03]; p < 0.001 and Δ6MWD -49.7 meters [-77.2, -22.1]; p = 0.001).
Conclusion
Higher SASP levels were associated with poorer physical function recovery in older patients hospitalized for ADHF. These findings suggest that inflammatory SASP biomarkers may improve risk stratification and potentially guide therapeutic strategies. REHAB-HF trial is registered at clinicaltrials.gov Clinical Trial Registry NCT02196038
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wake Forest University School of Medicine, Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Winston Salem, NC, USA.
- Wake Forest University School of Medicine, Department of Biostatistics and Data Science, Winston Salem, NC, USA.
- Wake Forest University School of Medicine, Department of Cardiovascular Medicine, Winston Salem, NC, USA.
- Duke University School of Medicine, Division of Cardiology, Department of Medicine, Durham, NC, USA.
- Duke University School of Medicine, Division of Physical Therapy, Department of Medicine, Durham, NC, USA.
- Thomas Jefferson University, Sidney Kimmel Medical College, Division of Cardiology, Philadelphia, PA, USA.
Zitieren
APA
Semelka, C. T., Ehrig, M. R., Pajewski, N. M., Kritchevsky, S. B., Kramer, P. A., Peters, A. E., Mentz, R. J., Pastva, A. M., Whellan, D. J., & Kitzman, D. W. (2026). Senescence Biomarkers Predict Physical Function and Clinical Outcomes After Heart Failure Hospitalization: Insights From REHAB-HF. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glag256
Vancouver
Semelka CT, Ehrig MR, Pajewski NM, Kritchevsky SB, Kramer PA, Peters AE, et al. Senescence Biomarkers Predict Physical Function and Clinical Outcomes After Heart Failure Hospitalization: Insights From REHAB-HF. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026. doi:10.1093/gerona/glag256
BibTeX
@article{Semelka2026,
author = {Semelka, Charles T and Ehrig, Molly R and Pajewski, Nicholas M and Kritchevsky, Stephen B and Kramer, Philip A and Peters, Anthony E and Mentz, Robert J and Pastva, Amy M and Whellan, David J and Kitzman, Dalane W},
title = {Senescence Biomarkers Predict Physical Function and Clinical Outcomes After Heart Failure Hospitalization: Insights From REHAB-HF},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
doi = {10.1093/gerona/glag256}
}
EUVIMED